Chitotriosidase and Neopterin as Potential Biomarkers for the Evaluation of Complicated Cholecystitis—A Pilot Study
Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on...
Saved in:
Published in | Journal of clinical medicine Vol. 12; no. 4; p. 1641 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
18.02.2023
MDPI |
Subjects | |
Online Access | Get full text |
ISSN | 2077-0383 2077-0383 |
DOI | 10.3390/jcm12041641 |
Cover
Abstract | Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on 51 patients with gallstones. Only subjects with normal renal, pancreatic, and hepatic functions were included. The severity of cholecystitis was evaluated by considering the ultrasound examination, intraoperative findings, and pathology report. We evaluated two potential biomarkers, namely neopterin and chitotriosidase, by comparing their levels before and after the intervention for chronic (n = 36) and complicated (n = 15) cases, as well as their eventual association with the hospitalization period. Subjects with complicated cholecystitis had significantly higher (p = 0.01) neopterin levels at presentation (16.82 nmol/L vs. 11.92 nmol/L, median values), but the differences in chitotriosidase activity between complicated (170.00 nmol/mL/h) and chronic (160.00 nmol/mL/h) cases were not significant (p = 0.66). Patients with neopterin levels above the cut-off value 14.69 nmol/L had a 3.34 times higher risk of complicated cholecystitis. Twenty-four hours after the laparoscopic cholecystectomy, the differences in neopterin level and chitotriosidase activity between chronic and complicated cases were not significant. A significant decrease in chitotriosidase activity was observed after the intervention, only for complicated cases (190 nmol/mL/h vs. 145 nmol/mL/h, p = 0.007); for neopterin, the postoperative decrease was not statistically significant (19.42 nmol/L vs. 10.92 nmol/L, p = 0.06). No significant association with the hospitalization period was observed. Neopterin may be a useful biomarker for complicated cholecystitis, and chitotriosidase may have prognostic utility in early patient follow-up. |
---|---|
AbstractList | Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on 51 patients with gallstones. Only subjects with normal renal, pancreatic, and hepatic functions were included. The severity of cholecystitis was evaluated by considering the ultrasound examination, intraoperative findings, and pathology report. We evaluated two potential biomarkers, namely neopterin and chitotriosidase, by comparing their levels before and after the intervention for chronic (n = 36) and complicated (n = 15) cases, as well as their eventual association with the hospitalization period. Subjects with complicated cholecystitis had significantly higher (p = 0.01) neopterin levels at presentation (16.82 nmol/L vs. 11.92 nmol/L, median values), but the differences in chitotriosidase activity between complicated (170.00 nmol/mL/h) and chronic (160.00 nmol/mL/h) cases were not significant (p = 0.66). Patients with neopterin levels above the cut-off value 14.69 nmol/L had a 3.34 times higher risk of complicated cholecystitis. Twenty-four hours after the laparoscopic cholecystectomy, the differences in neopterin level and chitotriosidase activity between chronic and complicated cases were not significant. A significant decrease in chitotriosidase activity was observed after the intervention, only for complicated cases (190 nmol/mL/h vs. 145 nmol/mL/h, p = 0.007); for neopterin, the postoperative decrease was not statistically significant (19.42 nmol/L vs. 10.92 nmol/L, p = 0.06). No significant association with the hospitalization period was observed. Neopterin may be a useful biomarker for complicated cholecystitis, and chitotriosidase may have prognostic utility in early patient follow-up. Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on 51 patients with gallstones. Only subjects with normal renal, pancreatic, and hepatic functions were included. The severity of cholecystitis was evaluated by considering the ultrasound examination, intraoperative findings, and pathology report. We evaluated two potential biomarkers, namely neopterin and chitotriosidase, by comparing their levels before and after the intervention for chronic ( n = 36) and complicated ( n = 15) cases, as well as their eventual association with the hospitalization period. Subjects with complicated cholecystitis had significantly higher ( p = 0.01) neopterin levels at presentation (16.82 nmol/L vs. 11.92 nmol/L, median values), but the differences in chitotriosidase activity between complicated (170.00 nmol/mL/h) and chronic (160.00 nmol/mL/h) cases were not significant ( p = 0.66). Patients with neopterin levels above the cut-off value 14.69 nmol/L had a 3.34 times higher risk of complicated cholecystitis. Twenty-four hours after the laparoscopic cholecystectomy, the differences in neopterin level and chitotriosidase activity between chronic and complicated cases were not significant. A significant decrease in chitotriosidase activity was observed after the intervention, only for complicated cases (190 nmol/mL/h vs. 145 nmol/mL/h, p = 0.007); for neopterin, the postoperative decrease was not statistically significant (19.42 nmol/L vs. 10.92 nmol/L, p = 0.06). No significant association with the hospitalization period was observed. Neopterin may be a useful biomarker for complicated cholecystitis, and chitotriosidase may have prognostic utility in early patient follow-up. Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on 51 patients with gallstones. Only subjects with normal renal, pancreatic, and hepatic functions were included. The severity of cholecystitis was evaluated by considering the ultrasound examination, intraoperative findings, and pathology report. We evaluated two potential biomarkers, namely neopterin and chitotriosidase, by comparing their levels before and after the intervention for chronic ( = 36) and complicated ( = 15) cases, as well as their eventual association with the hospitalization period. Subjects with complicated cholecystitis had significantly higher ( = 0.01) neopterin levels at presentation (16.82 nmol/L vs. 11.92 nmol/L, median values), but the differences in chitotriosidase activity between complicated (170.00 nmol/mL/h) and chronic (160.00 nmol/mL/h) cases were not significant ( = 0.66). Patients with neopterin levels above the cut-off value 14.69 nmol/L had a 3.34 times higher risk of complicated cholecystitis. Twenty-four hours after the laparoscopic cholecystectomy, the differences in neopterin level and chitotriosidase activity between chronic and complicated cases were not significant. A significant decrease in chitotriosidase activity was observed after the intervention, only for complicated cases (190 nmol/mL/h vs. 145 nmol/mL/h, = 0.007); for neopterin, the postoperative decrease was not statistically significant (19.42 nmol/L vs. 10.92 nmol/L, = 0.06). No significant association with the hospitalization period was observed. Neopterin may be a useful biomarker for complicated cholecystitis, and chitotriosidase may have prognostic utility in early patient follow-up. Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on 51 patients with gallstones. Only subjects with normal renal, pancreatic, and hepatic functions were included. The severity of cholecystitis was evaluated by considering the ultrasound examination, intraoperative findings, and pathology report. We evaluated two potential biomarkers, namely neopterin and chitotriosidase, by comparing their levels before and after the intervention for chronic (n = 36) and complicated (n = 15) cases, as well as their eventual association with the hospitalization period. Subjects with complicated cholecystitis had significantly higher (p = 0.01) neopterin levels at presentation (16.82 nmol/L vs. 11.92 nmol/L, median values), but the differences in chitotriosidase activity between complicated (170.00 nmol/mL/h) and chronic (160.00 nmol/mL/h) cases were not significant (p = 0.66). Patients with neopterin levels above the cut-off value 14.69 nmol/L had a 3.34 times higher risk of complicated cholecystitis. Twenty-four hours after the laparoscopic cholecystectomy, the differences in neopterin level and chitotriosidase activity between chronic and complicated cases were not significant. A significant decrease in chitotriosidase activity was observed after the intervention, only for complicated cases (190 nmol/mL/h vs. 145 nmol/mL/h, p = 0.007); for neopterin, the postoperative decrease was not statistically significant (19.42 nmol/L vs. 10.92 nmol/L, p = 0.06). No significant association with the hospitalization period was observed. Neopterin may be a useful biomarker for complicated cholecystitis, and chitotriosidase may have prognostic utility in early patient follow-up.Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of conversion, the duration, and the difficulty of the intervention, along with the hospitalization period. A prospective cohort study was conducted on 51 patients with gallstones. Only subjects with normal renal, pancreatic, and hepatic functions were included. The severity of cholecystitis was evaluated by considering the ultrasound examination, intraoperative findings, and pathology report. We evaluated two potential biomarkers, namely neopterin and chitotriosidase, by comparing their levels before and after the intervention for chronic (n = 36) and complicated (n = 15) cases, as well as their eventual association with the hospitalization period. Subjects with complicated cholecystitis had significantly higher (p = 0.01) neopterin levels at presentation (16.82 nmol/L vs. 11.92 nmol/L, median values), but the differences in chitotriosidase activity between complicated (170.00 nmol/mL/h) and chronic (160.00 nmol/mL/h) cases were not significant (p = 0.66). Patients with neopterin levels above the cut-off value 14.69 nmol/L had a 3.34 times higher risk of complicated cholecystitis. Twenty-four hours after the laparoscopic cholecystectomy, the differences in neopterin level and chitotriosidase activity between chronic and complicated cases were not significant. A significant decrease in chitotriosidase activity was observed after the intervention, only for complicated cases (190 nmol/mL/h vs. 145 nmol/mL/h, p = 0.007); for neopterin, the postoperative decrease was not statistically significant (19.42 nmol/L vs. 10.92 nmol/L, p = 0.06). No significant association with the hospitalization period was observed. Neopterin may be a useful biomarker for complicated cholecystitis, and chitotriosidase may have prognostic utility in early patient follow-up. |
Audience | Academic |
Author | Drugan, Cristina Moiş, Emil Cătană, Cristina-Sorina Nechita, Vlad-Ionuţ Nechita, Mihaela-Ancuţa Graur, Florin Hajjar, Nadim Al |
AuthorAffiliation | 5 Ion Chiricuță Oncology Institute, Republicii Str. No. 34–36, 400015 Cluj-Napoca, Romania 1 Department of Medical Informatics and Biostatistics, Iuliu Hațieganu University of Medicine and Pharmacy, Louis Pasteur Str. No. 6, 400349 Cluj-Napoca, Romania 3 Department of Surgery, Iuliu Hațieganu University of Medicine and Pharmacy, Croitorilor Str. No. 19–21, 400162 Cluj-Napoca, Romania 2 Octavian Fodor Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania 4 Department of Medical Biochemistry, Iuliu Haţieganu University of Medicine and Pharmacy, Louis Pasteur Str. No. 6, 400349 Cluj-Napoca, Romania |
AuthorAffiliation_xml | – name: 2 Octavian Fodor Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania – name: 4 Department of Medical Biochemistry, Iuliu Haţieganu University of Medicine and Pharmacy, Louis Pasteur Str. No. 6, 400349 Cluj-Napoca, Romania – name: 3 Department of Surgery, Iuliu Hațieganu University of Medicine and Pharmacy, Croitorilor Str. No. 19–21, 400162 Cluj-Napoca, Romania – name: 1 Department of Medical Informatics and Biostatistics, Iuliu Hațieganu University of Medicine and Pharmacy, Louis Pasteur Str. No. 6, 400349 Cluj-Napoca, Romania – name: 5 Ion Chiricuță Oncology Institute, Republicii Str. No. 34–36, 400015 Cluj-Napoca, Romania |
Author_xml | – sequence: 1 givenname: Vlad-Ionuţ surname: Nechita fullname: Nechita, Vlad-Ionuţ – sequence: 2 givenname: Nadim Al surname: Hajjar fullname: Hajjar, Nadim Al – sequence: 3 givenname: Cristina orcidid: 0000-0001-9136-2530 surname: Drugan fullname: Drugan, Cristina – sequence: 4 givenname: Cristina-Sorina surname: Cătană fullname: Cătană, Cristina-Sorina – sequence: 5 givenname: Emil surname: Moiş fullname: Moiş, Emil – sequence: 6 givenname: Mihaela-Ancuţa surname: Nechita fullname: Nechita, Mihaela-Ancuţa – sequence: 7 givenname: Florin orcidid: 0000-0002-5887-3408 surname: Graur fullname: Graur, Florin |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36836175$$D View this record in MEDLINE/PubMed |
BookMark | eNptkk1rFDEYxwep2Fp78i4BL4JszdtMJhdhHeoLFC2o55DJPOlmzUy2SaawNz-En9BPYmpb3ZYmh4Tk9_zgnzxPq70pTFBVzwk-ZkziN2szEoo5aTh5VB1QLMQCs5bt7ez3q6OU1riMtuWUiCfVPmta1hBRH1Rzt3I55OhCcoNOgPQ0oM8QNhmim5BO6CxkmLLTHr1zYdTxB8SEbIgorwCdXGo_6-zChIJFXRg33hmdYUDdKngw25Rddun3z19LdOZ8yOhrnofts-qx1T7B0c16WH1_f_Kt-7g4_fLhU7c8XRgumrywhltBGeW64YxA29C-t0BryqTpSU-Y5MDqgWvbatpY3EKPqQRt64HqltXssHp77d3M_QiDKUGi9moTXQmyVUE7dfdmcit1Hi6VlA2XEhfBqxtBDBczpKxGlwx4rycIc1JUtBg3VIq2oC_voeswx6nEK5SQRdfU_D91rj0oN9ny9tpcSdVS1JgxLmtSqOMHqDIHGJ0pHWBdOb9T8GI36L-Etx9dAHINmBhSimCVcfnvxxWz84pgddVPaqefSs3rezW32ofoP4DAzGQ |
CitedBy_id | crossref_primary_10_3390_biomedicines11051294 crossref_primary_10_3390_jcm12216946 crossref_primary_10_4274_imj_galenos_2024_94467 |
Cites_doi | 10.5009/gnl.2012.6.2.172 10.1007/s10620-006-9107-3 10.1093/clinchem/33.1.62 10.2174/1389200024605082 10.1155/2016/2682680 10.4103/0019-5278.44690 10.5505/tjtes.2012.00087 10.3390/antiox7070080 10.1016/S0002-9610(05)80930-4 10.3390/diagnostics11020263 10.1186/s13017-015-0005-x 10.1074/jbc.270.5.2198 10.1016/j.ajem.2011.04.006 10.1093/intimm/dxh328 10.3889/oamjms.2021.5465 10.3390/ijms22136966 10.1172/JCI117084 10.1002/jcla.20063 10.1046/j.1440-1622.2000.01851.x 10.1007/s00534-006-1159-4 10.1007/978-981-13-7318-3_11 10.1007/s00011-003-1181-9 10.9738/INTSURG-D-13-00222.1 10.1148/radiographics.20.3.g00ma16751 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2023 MDPI AG 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 by the authors. 2023 |
Copyright_xml | – notice: COPYRIGHT 2023 MDPI AG – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 by the authors. 2023 |
DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.3390/jcm12041641 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X7 name: Health & Medical Collection (ProQuest) url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2077-0383 |
ExternalDocumentID | PMC9964990 A750334951 36836175 10_3390_jcm12041641 |
Genre | Journal Article |
GeographicLocations | Romania |
GeographicLocations_xml | – name: Romania |
GrantInformation_xml | – fundername: Iuliu Hațieganu University of Medicine and Pharmacy grantid: PCD 1529/50/18.01.2019 – fundername: “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Doctoral Research Program grantid: PCD 1529/50 |
GroupedDBID | 53G 5VS 7X7 8FI 8FJ AADQD AAFWJ AAYXX ABDBF ABUWG ACUHS ADBBV AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU CITATION DIK FYUFA HMCUK HYE IAO IHR ITC KQ8 M48 MODMG M~E OK1 PGMZT PHGZM PHGZT PIMPY RPM UKHRP GROUPED_DOAJ NPM PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c476t-fc4f72324a6431e862bbfe25239cb1b1394e35d4af8a26f08eb029eaf5d2a8353 |
IEDL.DBID | M48 |
ISSN | 2077-0383 |
IngestDate | Thu Aug 21 18:37:43 EDT 2025 Fri Sep 05 03:23:12 EDT 2025 Sun Jun 29 16:10:08 EDT 2025 Tue Jun 17 22:20:25 EDT 2025 Tue Jun 10 21:12:53 EDT 2025 Thu Jan 02 22:53:00 EST 2025 Thu Apr 24 23:05:43 EDT 2025 Tue Jul 01 02:09:45 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | complicated cholecystitis chitotriosidase neopterin laparoscopic cholecystectomy |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c476t-fc4f72324a6431e862bbfe25239cb1b1394e35d4af8a26f08eb029eaf5d2a8353 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-5887-3408 0000-0001-9136-2530 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/jcm12041641 |
PMID | 36836175 |
PQID | 2779499654 |
PQPubID | 5046890 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9964990 proquest_miscellaneous_2780062978 proquest_journals_2779499654 gale_infotracmisc_A750334951 gale_infotracacademiconefile_A750334951 pubmed_primary_36836175 crossref_citationtrail_10_3390_jcm12041641 crossref_primary_10_3390_jcm12041641 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20230218 |
PublicationDateYYYYMMDD | 2023-02-18 |
PublicationDate_xml | – month: 2 year: 2023 text: 20230218 day: 18 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Journal of clinical medicine |
PublicationTitleAlternate | J Clin Med |
PublicationYear | 2023 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Kumar (ref_10) 2019; 1142 Kamal (ref_24) 2021; 9 Dal (ref_25) 2018; 25 Sakorafas (ref_3) 2007; 52 Hoffmann (ref_19) 2003; 52 Pingle (ref_16) 2008; 12 Hirota (ref_26) 2007; 14 Renkema (ref_11) 2005; 17 Elmonem (ref_13) 2016; 2016 ref_17 Werner (ref_21) 1987; 33 ref_15 Acar (ref_22) 2012; 30 Bortoff (ref_4) 2000; 20 Malaguarnera (ref_12) 2005; 19 Sugrue (ref_29) 2015; 10 Prakash (ref_28) 2022; 14 Kapan (ref_7) 2015; 100 Renkema (ref_14) 1995; 270 ref_20 Mentes (ref_23) 2012; 18 Stinton (ref_2) 2012; 6 Murr (ref_18) 2002; 3 ref_1 Hunt (ref_8) 2000; 70 Hollak (ref_27) 1994; 93 ref_9 ref_5 ref_6 |
References_xml | – volume: 6 start-page: 172 year: 2012 ident: ref_2 article-title: Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer publication-title: Gut Liver doi: 10.5009/gnl.2012.6.2.172 – volume: 52 start-page: 1313 year: 2007 ident: ref_3 article-title: Asymptomatic Cholelithiasis: Is Cholecystectomy Really Needed? A Critical Reappraisal 15 Years after the Introduction of Laparoscopic Cholecystectomy publication-title: Dig. Dis. Sci. doi: 10.1007/s10620-006-9107-3 – ident: ref_5 – volume: 33 start-page: 62 year: 1987 ident: ref_21 article-title: Determination of Neopterin in Serum and Urine publication-title: Clin. Chem. doi: 10.1093/clinchem/33.1.62 – volume: 3 start-page: 175 year: 2002 ident: ref_18 article-title: Neopterin as a Marker for Immune System Activation publication-title: Curr. Drug Metab. doi: 10.2174/1389200024605082 – volume: 2016 start-page: e2682680 year: 2016 ident: ref_13 article-title: Immunomodulatory Effects of Chitotriosidase Enzyme publication-title: Enzym. Res. doi: 10.1155/2016/2682680 – volume: 12 start-page: 107 year: 2008 ident: ref_16 article-title: Neopterin: Biomarker of Cell-Mediated Immunity and Potent Usage as Biomarker in Silicosis and Other Occupational Diseases publication-title: Indian J. Occup. Environ. Med. doi: 10.4103/0019-5278.44690 – volume: 18 start-page: 1 year: 2012 ident: ref_23 article-title: Is Neopterin a Diagnostic Marker of Acute Appendicitis? publication-title: Ulus. Travma Ve Acil Cerrahi Derg. doi: 10.5505/tjtes.2012.00087 – ident: ref_20 doi: 10.3390/antiox7070080 – ident: ref_6 doi: 10.1016/S0002-9610(05)80930-4 – ident: ref_9 doi: 10.3390/diagnostics11020263 – ident: ref_1 – volume: 10 start-page: 14 year: 2015 ident: ref_29 article-title: Grading Operative Findings at Laparoscopic Cholecystectomy—A New Scoring System publication-title: World J. Emerg. Surg. doi: 10.1186/s13017-015-0005-x – volume: 270 start-page: 2198 year: 1995 ident: ref_14 article-title: Purification and Characterization of Human Chitotriosidase, a Novel Member of the Chitinase Family of Proteins publication-title: J. Biol. Chem. doi: 10.1074/jbc.270.5.2198 – volume: 30 start-page: 775 year: 2012 ident: ref_22 article-title: Serum Chitotriosidase Activity in Acute Appendicitis: Preliminary Results publication-title: Am. J. Emerg. Med. doi: 10.1016/j.ajem.2011.04.006 – volume: 17 start-page: 1505 year: 2005 ident: ref_11 article-title: Characterization of Human Phagocyte-Derived Chitotriosidase, a Component of Innate Immunity publication-title: Int. Immunol. doi: 10.1093/intimm/dxh328 – volume: 9 start-page: 42 year: 2021 ident: ref_24 article-title: Comparative Study between Neopterin and Alvarado Score in the Diagnosis of Acute Appendicitis and Its Severity publication-title: Open Access Maced. J. Med. Sci. doi: 10.3889/oamjms.2021.5465 – volume: 25 start-page: 229 year: 2018 ident: ref_25 article-title: Role of Alvarado Score and Biological Indicators of C-Reaktif Protein, Procalicitonin and Neopterin in Diagnosis of Acute Appendicitis publication-title: Ulus. Travma Ve Acil Cerrahi Derg. – ident: ref_15 doi: 10.3390/ijms22136966 – volume: 93 start-page: 1288 year: 1994 ident: ref_27 article-title: Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease publication-title: J. Clin. Investig. doi: 10.1172/JCI117084 – volume: 19 start-page: 128 year: 2005 ident: ref_12 article-title: Interferon-Gamma, Tumor Necrosis Factor-Alpha, and Lipopolysaccharide Promote Chitotriosidase Gene Expression in Human Macrophages publication-title: J. Clin. Lab. Anal. doi: 10.1002/jcla.20063 – volume: 70 start-page: 428 year: 2000 ident: ref_8 article-title: Gangrenous Cholecystitis in the Laparoscopic Era publication-title: Aust. N. Z. J. Surg. doi: 10.1046/j.1440-1622.2000.01851.x – volume: 14 start-page: 78 year: 2007 ident: ref_26 article-title: Diagnostic Criteria and Severity Assessment of Acute Cholecystitis: Tokyo Guidelines publication-title: J. Hepatobiliary Pancreat. Surg. doi: 10.1007/s00534-006-1159-4 – volume: 1142 start-page: 221 year: 2019 ident: ref_10 article-title: Human Chitinases: Structure, Function, and Inhibitor Discovery publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-981-13-7318-3_11 – volume: 52 start-page: 313 year: 2003 ident: ref_19 article-title: Potential Role of Immune System Activation-Associated Production of Neopterin Derivatives in Humans publication-title: Inflamm. Res. doi: 10.1007/s00011-003-1181-9 – ident: ref_17 – volume: 100 start-page: 254 year: 2015 ident: ref_7 article-title: Gangrenous Cholecystitis: Mortality and Risk Factors publication-title: Int. Surg. doi: 10.9738/INTSURG-D-13-00222.1 – volume: 14 start-page: e32243 year: 2022 ident: ref_28 article-title: The Accuracy of Neutrophil-to-Lymphocyte Ratio and Abdominal Computed Tomography to Predict the Severity of Acute Cholecystitis publication-title: Cureus – volume: 20 start-page: 751 year: 2000 ident: ref_4 article-title: Gallbladder Stones: Imaging and Intervention publication-title: Radiographics doi: 10.1148/radiographics.20.3.g00ma16751 |
SSID | ssj0000884217 |
Score | 2.2564077 |
Snippet | Gallstones are a common surgical pathology. Laparoscopic cholecystectomy represents the elective treatment. Complicated cases can increase the rate of... |
SourceID | pubmedcentral proquest gale pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1641 |
SubjectTerms | Analysis Appendicitis Asymptomatic Biochemistry Biological markers Biomarkers Blood & organ donations Cholecystectomy Cholecystitis Diagnosis Enzymes Evaluation Gallbladder Gallbladder diseases Gallstones Gangrene Gastroenterology Hepatology Heterocyclic compounds Histopathology Hospitalization Identification and classification Inflammation Interferon Laparoscopy Normal distribution Pathology Patients Risk factors Tumor necrosis factor-TNF Ultrasonic imaging |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fS9xAEF9aC9IXsa2tsbZsQRCEYJLd_LknOQ9FCooPFe4t7F9M0ex5yT345ofoJ-wn6UxuL16k-LyTZMnM7Pxm97czhBxoxnTKtAwNZ1nICyNCyUYqTBSHcMqMjCxu6F9eZRc3_Oc0nfoNt8bTKldrYrdQa6dwj_w4yXOso5Kl_GT2EGLXKDxd9S003pJ3MUAVtOp8mvd7LOBBHCD38loeg-z--Le6j5MIQAiPB4Ho5XK8Fo-GXMm14HO-TbY8aqTjpZo_kDem_kg2L_25-CeymNyCZ7bzyoFxQVyiotb0yrgZVmKuqWjotWuRFwQvOa3cPXJy5g0FwEoBANKzvuQ3dZZOVixzo-mka5_7iISCqvn79GdMr6s711KkHz7ukJvzs1-Ti9A3VAgVz7M2tIrbHCGUABwSG0hmpLQmgVx0pGQsAQxyw1LNhS1EktmoAFUlIyNsqhMBUI19Jhu1q80uoVFhc11wpbTCAj1WgrSWGRPWMryNG5Cj1d8tla82jk0v7krIOlAV5ZoqAnLQC8-WRTb-L3aIairR9eBdSvgbBDAjLGJVjrszWcj4QHJ_IAkuo4bDK0WX3mWb8tnAAvKjH8YnkYZWG7dAmQIvnULmHZAvS7voJ8yyggEcTAOSDyymF8BC3sORurrtCnrDV-HL0d7r0_pK3mOve6SMx8U-2WjnC_MNEFErv3dm_w-hSg8Z priority: 102 providerName: ProQuest |
Title | Chitotriosidase and Neopterin as Potential Biomarkers for the Evaluation of Complicated Cholecystitis—A Pilot Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36836175 https://www.proquest.com/docview/2779499654 https://www.proquest.com/docview/2780062978 https://pubmed.ncbi.nlm.nih.gov/PMC9964990 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2077-0383 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884217 issn: 2077-0383 databaseCode: KQ8 dateStart: 20120101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2077-0383 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884217 issn: 2077-0383 databaseCode: ABDBF dateStart: 20160901 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2077-0383 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884217 issn: 2077-0383 databaseCode: DIK dateStart: 20120101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources (ISSN International Center) customDbUrl: eissn: 2077-0383 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884217 issn: 2077-0383 databaseCode: M~E dateStart: 20120101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central (US National Library of Medicine) customDbUrl: eissn: 2077-0383 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884217 issn: 2077-0383 databaseCode: RPM dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection (ProQuest) customDbUrl: eissn: 2077-0383 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884217 issn: 2077-0383 databaseCode: 7X7 dateStart: 20190101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central Database Suite (ProQuest) customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2077-0383 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000884217 issn: 2077-0383 databaseCode: BENPR dateStart: 20190101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2077-0383 dateEnd: 20250831 omitProxy: true ssIdentifier: ssj0000884217 issn: 2077-0383 databaseCode: M48 dateStart: 20120101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NattAEF7SBEIupf9Vm5otBAoFtbJ2Ja0PpTjGIRRsTKnBN7G_RMGRUluG-JaH6BP2STojS8IKOfW8s9pFM6v5RjvzDSFnhjETMaN8y1nsc2Glr9hA-6Hm4E6ZVYHDH_qTaXw55z8W0eKANM046xe4fjS0w35S89Xyy93v7Xc48N8w4oSQ_eu1vumHASALLGA_ApcUonlPapxffZKF4IC9d_V5D-eckGMWCwauPOo4p4ef6D0f1c2f3HNIF8_I0xpJ0uFO9c_Jgc1fkONJfVf-kmxGV3Bay1VWgMGBr6IyN3Rqi1tkZ86pXNNZUWKuEDzkPCtuME9ntaYAYimAQjpuacBp4eioyTy3ho6qlrpbTDLI1n_v_wzpLFsWJcWUxO0rMr8Y_xpd-nWTBV_zJC59p7lLEFZJwCZ9CwGOUs6GEJ8OtOorAIjcsshw6YQMYxcIUF84sNJFJpQA39hrcpgXuX1LaCBcYgTX2mgk7XEKpI2KmXSOYYWuRz43bzfVNQM5NsJYphCJoFbSPa145KwVvt0Rbzwu9gnVlKKBwLO0rKsKYEdIbJUOq3taiAJB8rQjCcdId4cbRaeNFaZhkiB5Txxxj3xsh3EmpqblttigjMBCVIjGPfJmZxfthhu78kjSsZhWAMm9uyN5dlWRfMOqsHLw7r9nvicnIQAyzDDvi1NyWK429gMAqFL1yJNkkfTI0fl4OvvZq47KP8rpIQM |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9NAFB5VRQIuiB3TAoNUhIRk1Z4ZLzkgFEKrlDZRD62UmxnPohq1dpo4QrnxI_gd_Ch-Ce95I0aIW8_zbI_8tu_NvIWQPc25DrhOXSN46IrYSDflA-UyJcCdcpN6Fg_0J9NwfC4-z4LZFvnZ1sJgWmVrEytDrQuFZ-T7LIqwj0oYiA_zaxenRuHtajtCoxaLY7P-BiHb8v3RJ-DvG8YOD85GY7eZKuAqEYWla5WwEeIICc7YN4Do09QaBgHZQKV-CohIGB5oIW0sWWi9GPbLBkbaQDMZV1MiwOTfEtwT2Ks_mkXdmQ5orACIX5cBcj7w9r-qK595AHqE33N8f5v_Df_Xz83ccHaH98m9BqXSYS1WD8iWyR-S25PmHv4RWY0uwBKUi6wAYQY_SGWu6dQUc-z8nFO5pKdFiXlI8JKPWXGFOUCLJQWATAFw0oOuxTgtLB21We1G01E1rneNCQzZ8tf3H0N6ml0WJcV0x_Vjcn4jv_oJ2c6L3Dwj1IttpGOhlFbYEMimQK3TkEtrOVb_OuRd-3cT1XQ3xyEblwlEOciKZIMVDtnriOd1U49_k71FNiWo6vAuJZuKBdgRNs1KhtUdMESYQLnbowQVVf3lltFJYyKWyR-BdsjrbhmfxLS33BQrpImxyBUifYc8reWi2zAPYw7wM3BI1JOYjgAbh_dX8uyiaiAOX4Uve8__v61X5M74bHKSnBxNj3fIXQboDtPV_XiXbJeLlXkBaKxMX1YqQMmXm9a53yoyTBE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VRaq4IN4YCixSERKSFXt3_cgBoZA2aimNcqBSbsb7UlO1dogdodz4Efwafg6_hBm_iBHi1vOO7ZV3Ht_sfjtDyIHmXAdcS9cIHroiNqkr-VC5TAkIp9xIz-KG_tk0PD4XH-fBfIf8bO_CIK2y9YmVo9a5wj3yAYsirKMSBmJgG1rE7HDyfvnVxQ5SeNLattOoVeTUbL5B-la8OzmEtX7N2OTo8_jYbToMuEpEYelaJWyEmCKFwOwbQPdSWsMgORsq6UtAR8LwQIvUxikLrRfD3NnQpDbQLI2rjhHg_m9FXHCkk0XzqNvfAesVAPfrK4GcD73Bpbr2mQcASPi9IPh3KNiKhX2e5lbgm9wldxrESke1it0jOya7T_bOmjP5B2Q9vgCvUK4WOSg2xESaZppOTb7EKtAZTQs6y0vkJMFLPizya-QDrQoKYJkC-KRHXblxmls6bhnuRtNx1bp3g2SGRfHr-48RnS2u8pIi9XHzkJzfyK9-RHazPDNPCPViG-lYKKUVFgeyEqS1DHlqLcebwA552_7dRDWVzrHhxlUCGQ8uRbK1FA456ISXdYGPf4u9wWVK0OzhXSptbi_AjLCAVjKqzoMh2wTJ_Z4kmKvqD7cLnTTuokj-KLdDXnXD-CRS4DKTr1EmxguvkPU75HGtF92EeRhzgKKBQ6KexnQCWES8P5ItLqpi4vBV-LL39P_Tekn2wNqSTyfT02fkNgOgh8x1P94nu-VqbZ4DMCvli8oCKPly0yb3G2lyUEw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chitotriosidase+and+Neopterin+as+Potential+Biomarkers+for+the+Evaluation+of+Complicated+Cholecystitis%E2%80%94A+Pilot+Study&rft.jtitle=Journal+of+clinical+medicine&rft.au=Nechita%2C+Vlad-Ionu%C5%A3&rft.au=Hajjar%2C+Nadim+Al&rft.au=Drugan%2C+Cristina&rft.au=C%C4%83tan%C4%83%2C+Cristina-Sorina&rft.date=2023-02-18&rft.pub=MDPI&rft.eissn=2077-0383&rft.volume=12&rft.issue=4&rft_id=info:doi/10.3390%2Fjcm12041641&rft_id=info%3Apmid%2F36836175&rft.externalDocID=PMC9964990 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2077-0383&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2077-0383&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2077-0383&client=summon |